NISMAT is a pioneering hospital-based facility that’s solely dedicated to sports medicine. NISMAT has been at the forefront of advancing the field since our establishment in 1973 at Lenox Hill ...

Edmund Mehring and his partner, Audrey Gerber, were strolling down a tree-lined street in lower Manhattan when he spotted a man sprinting toward them, a gaggle of police officers close behind. Mehring ...

We believe that athletes should have access to coordinated care to ensure their safety and well-being during practice and competition. Through our certified athletic trainer services, we provide ...

We offer renowned cardiac services and access to Northwell’s extensive network of resources, including research and clinical trials.

Treatment for pelvis fracture can take a variety of forms. The pelvis is the ring of bones at the base of the spine; it creates a basin-like structure that encloses many vital organs, including the ...

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial ...

As the largest health-based laboratory in the region, Northwell Health Labs provides a wide range of lab services from highly trained, compassionate experts. And we’re right where you need us in Rego ...

A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) ...

NACHO-BIO: A Translational Biology Platform to Advance Understanding of Pathogenesis and Improve Outcomes for Patients with Histiocytic Disorders ...

This phase III trial compares the effects of nivolumab with chemo-immunotherapy versus chemo-immunotherapy alone in treating patients with newly diagnosed primary mediastinal B-cell lymphoma (PMBCL).

This randomized phase III trial investigates how well imatinib mesylate works in combination with two different chemotherapy regimens in treating patients with newly diagnosed Philadelphia chromosome ...

The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).